Holen Sie sich die Stockscreener-App
0.4799
9.81%
-0.0522
Handel nachbörslich:
.47
-0.0099
-2.06%
Finanzdaten der Jasper Therapeutics Inc-Aktie (JSPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Cost Of Revenue |
1.08%
3.584
|
3.623 | 6.761 | 9.345 | - |
| Operating Expenses |
15.93%
9.207
|
10.95 | 15.84 | 19.17 | 27.08 |
| Depreciation and Amortization |
0.00%
0.021
|
0.021 | 0.29 | 0.229 | 0.258 |
| Operating Income/Loss |
15.93%
-9.207
|
-10.95 | -15.84 | -19.17 | -27.08 |
| Nonoperating Income/Loss |
34.07%
6.447
|
9.778 | 6.738 | 0.43 | 0.353 |
| Net Income/Loss |
135.09%
-2.76
|
-1.174 | -9.101 | -18.74 | -26.72 |
| Basic Average Shares |
0.09%
28.70
|
28.67 | - | 16.64 | 15.33 |
| Diluted Average Shares |
0.09%
28.70
|
28.67 | - | 16.64 | 15.33 |
| Basic Earnings Per Share |
150.00%
-0.10
|
-0.04 | - | -1.13 | -1.74 |
| Diluted Earnings Per Share |
150.00%
-0.10
|
-0.04 | - | -1.13 | -1.74 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):